355 Directing a high avidity KRAS G12D-specific TCR engineered with a CD8αβ co-receptor and chimeric cytokine receptor using non-viral knock-in enhances anti-tumor responses - Philip D Greenberg; Christopher A Klebanoff; Kim Nguyen; Gary Shapiro; Joshua Francis; Cheryl Black; Anthony Thomas; Meghan D Storlie; Allison P Drain; Nicholas Rouillard; Nathaniel Swanson; Santosh Narayan; et al. (Journal for ImmunoTherapy of Cancer, 2023)